Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Van Overbeke

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Animal Genetics|March 13, 2012
Genetic polymorphisms in bovine transferrin receptor 2 (TFR2) and solute carrier family 40 (iron-regulated transporter), member 1 (SLC40A1) genes and their association with beef iron contentQ Duan, R G Tait, M S Mayes, et al.
Journal of Viral Hepatitis|May 16, 2017
The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experienceR Bielen, C Moreno, H Van Vlierberghe, et al.
Journal of Medical Virology|July 1, 2015
Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugsA Arain, S Bourgeois, C de Galocsy, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Animal Genetics|March 13, 2012
Genetic polymorphisms in bovine transferrin receptor 2 (TFR2) and solute carrier family 40 (iron-regulated transporter), member 1 (SLC40A1) genes and their association with beef iron contentQ Duan, R G Tait, M S Mayes, et al.
Journal of Viral Hepatitis|May 16, 2017
The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experienceR Bielen, C Moreno, H Van Vlierberghe, et al.
Journal of Medical Virology|July 1, 2015
Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugsA Arain, S Bourgeois, C de Galocsy, et al.
Pageof 2